|
🐜
|
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.
21 auth.
D. Black,
P. Delmas,
R. Eastell,
I. Reid,
S. Boonen,
J. Cauley,
F. Cosman,
P. Lakatos,
P. Leung,
Z. Man,
...
C. Mautalen,
P. Mesenbrink,
Huilin Hu,
J. Caminis,
K. Tong,
T. Rosario-Jansen,
J. Krasnow,
T. Hue,
D. Sellmeyer,
E. Eriksen,
S. Cummings
|
11 |
2007 |
11
🐜
|
|
🐜
|
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
40 auth.
L. Peyrin-Biroulet,
W. Sandborn,
B. Sands,
W. Reinisch,
W. Reinisch,
W. Bemelman,
R. Bryant,
G. D'Haens,
I. Dotan,
Marla C. Dubinsky,
B. Feagan,
G. Fiorino,
R. Gearry,
S. Krishnareddy,
P. Lakatos,
...
E. Loftus,
P. Marteau,
P. Munkholm,
T. Murdoch,
I. Ordás,
R. Panaccione,
R. Riddell,
J. Ruel,
D. Rubin,
M. Samaan,
C. Siegel,
M. Silverberg,
J. Stoker,
S. Schreiber,
S. Travis,
G. V. Assche,
G. Assche,
S. Danese,
J. Panés,
G. Bouguen,
S. O’Donnell,
B. Pariente,
S. Winer,
S. Hanauer,
J. Colombel
|
10 |
2015 |
10
🐜
|
|
🐢
|
The burden of inflammatory bowel disease in Europe.
J. Burisch,
T. Jess,
M. Martinato,
P. Lakatos
|
9 |
2013 |
9
🐢
|
|
🐜
|
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
58 auth.
A. Agostoni,
E. Aygören‐Pürsün,
K. Binkley,
A. Blanch,
K. Bork,
L. Bouillet,
C. Bucher,
A. Castaldo,
M. Cicardi,
A. Davis,
C. de Carolis,
C. Drouet,
C. Duponchel,
H. Farkas,
Kálmán Fáy,
...
B. Fekete,
B. Fischer,
L. Fontana,
G. Füst,
R. Giacomelli,
A. Gröner,
C. Erik Hack,
G. Harmat,
John Jakenfelds,
Mathias Juers,
L. Kalmár,
Pál N. Kaposi,
I. Karádi,
Arianna Kitzinger,
Tímea Kollár,
W. Kreuz,
P. Lakatos,
H. Longhurst,
M. López-Trascasa,
I. Martínez-Saguer,
N. Monnier,
I. Nagy,
É. Németh,
E. W. Nielsen,
J. Nuijens,
C. O'Grady,
E. Pappalardo,
V. Penna,
C. Perricone,
R. Perricone,
U. Rauch,
O. Roche,
E. Rusicke,
P. Späth,
G. Szendei,
E. Takács,
A. Tordai,
L. Truedsson,
L. Varga,
B. Visy,
Kayla Williams,
A. Zanichelli,
L. Zingale
|
9 |
2004 |
9
🐜
|
|
🐜
|
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.
21 auth.
M. Harbord,
V. Annese,
S. Vavricka,
M. Allez,
M. Barreiro-de Acosta,
K. Boberg,
J. Burisch,
M. De Vos,
A. de Vries,
A. Dick,
...
P. Juillerat,
T. Karlsen,
I. Koutroubakis,
P. Lakatos,
T. Orchard,
P. Papay,
T. Raine,
M. Reinshagen,
D. Thąci,
H. Tilg,
F. Carbonnel
|
9 |
2016 |
9
🐜
|
|
🐜
|
The Effect of 3 Versus 6 Years of Zoledronic Acid Treatment of Osteoporosis: A Randomized Extension to the HORIZON-Pivotal Fracture Trial (PFT)
17 auth.
D. Black,
I. Reid,
S. Boonen,
C. Bucci-Rechtweg,
J. Cauley,
F. Cosman,
S. Cummings,
T. Hue,
K. Lippuner,
P. Lakatos,
...
P. Leung,
Z. Man,
R. Martinez,
M. Tan,
M. Ruzycky,
Guoqin Su,
R. Eastell
|
9 |
2011 |
9
🐜
|
|
🐜
|
Geographical variability and environmental risk factors in inflammatory bowel disease
9 auth.
S. Ng,
C. Bernstein,
M. Vatn,
P. Lakatos,
E. Loftus,
C. Tysk,
...
C. O'Morain,
B. Moum,
J. Colombel
|
9 |
2013 |
9
🐜
|
|
🐜
|
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.
35 auth.
T. Raine,
S. Bonovas,
J. Burisch,
T. Kucharzik,
M. Adamina,
V. Annese,
O. Bachmann,
D. Bettenworth,
M. Chaparro-Sanchez,
W. Czuber-Dochan,
P. Eder,
P. Ellul,
C. Fidalgo,
G. Fiorino,
P. Gionchetti,
...
J. Gisbert,
H. Gordon,
C. Hedin,
S. Holubar,
M. Iacucci,
K. Karmiris,
K. Katsanos,
U. Kopylov,
P. Lakatos,
T. Lytras,
I. Lyutakov,
N. Noor,
G. Pellino,
D. Piovani,
E. Savarino,
F. Selvaggi,
B. Verstockt,
A. Spinelli,
Y. Panis,
G. Doherty
|
9 |
2021 |
9
🐜
|
|
🦁
|
Recent trends in the epidemiology of inflammatory bowel diseases: up or down?
P. Lakatos
|
8 |
2006 |
8
🦁
|
|
🦁
|
Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies.
P. Lakatos,
L. Lakatos
|
8 |
2008 |
8
🦁
|
|
🐜
|
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
16 auth.
D. Kendler,
F. Marin,
C. Zerbini,
L. A. Russo,
S. Greenspan,
V. Zikán,
A. Bagur,
J. Malouf-Sierra,
P. Lakatos,
A. Fahrleitner-Pammer,
...
E. Lespessailles,
S. Minisola,
J. Body,
P. Geusens,
R. Möricke,
P. López-Romero
|
8 |
2017 |
8
🐜
|
|
🐜
|
East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort
55 auth.
J. Burisch,
N. Pedersen,
S. Cukovic-Cavka,
M. Brinar,
I. Kaimakliotis,
D. Ďuricová,
O. Shonová,
I. Vind,
S. Avnstrøm,
N. Thorsgaard,
V. Andersen,
Simon Laiggard Krabbe,
J. Dahlerup,
R. Salupere,
K. Nielsen,
...
J. Olsen,
Pekka Manninen,
P. Collin,
E. Tsianos,
K. Katsanos,
K. Ladefoged,
L. Lakatos,
Einar Björnsson,
G. Ragnarsson,
Y. Bailey,
S. Odes,
D. Schwartz,
M. Martinato,
G. Lupinacci,
M. Milla,
A. Padova,
R. D'Incà,
M. Beltrami,
L. Kupčinskas,
G. Kiudelis,
S. Turcan,
O. Tighineanu,
I. Mihu,
F. Magro,
F. Magro,
L. Barros,
A. Goldiş,
D. Lazăr,
E. Belousova,
I. Nikulina,
V. Hernández,
D. Martínez-Ares,
S. Almér,
Y. Zhulina,
J. Halfvarson,
N. Arebi,
S. Sebastian,
P. Lakatos,
E. Langholz,
P. Munkholm
|
8 |
2013 |
8
🐜
|
|
🐜
|
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
22 auth.
B. Langdahl,
C. Libanati,
D. Crittenden,
M. Bolognese,
Jacques P. Brown,
N. Daizadeh,
E. Dokoupilova,
K. Engelke,
J. Finkelstein,
H. Genant,
...
S. Goemaere,
L. Hyldstrup,
E. Jódar-Gimeno,
T. Keaveny,
D. Kendler,
P. Lakatos,
J. Maddox,
J. Malouf,
F. Massari,
J. Molina,
M. Ulla,
A. Grauer
|
8 |
2017 |
8
🐜
|
